VitaSpring Biomedical Co. Ltd.
VSBC
$1.00
$0.000.00%
OTC PK
| 10/31/2022 | 07/31/2022 | 04/30/2022 | 01/31/2022 | 10/31/2021 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 1.49M | 3.49M | 200.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 1.49M | 3.49M | 200.00K |
| Cost of Revenue | -- | -- | 922.00K | 2.03M | 180.00K |
| Gross Profit | -- | -- | 568.00K | 1.46M | 20.00K |
| SG&A Expenses | 182.90K | 170.50K | 220.70K | 270.20K | 157.50K |
| Depreciation & Amortization | -- | 3.80K | 3.80K | 3.80K | -- |
| Other Operating Expenses | -- | -- | -- | 400.00 | -- |
| Total Operating Expenses | 182.90K | 174.30K | 1.15M | 2.30M | 337.50K |
| Operating Income | -182.90K | -174.30K | 343.50K | 1.19M | -137.50K |
| Income Before Tax | -183.60K | -174.50K | 351.60K | 1.19M | -137.50K |
| Income Tax Expenses | -45.60K | -30.30K | 75.00K | 246.90K | -- |
| Earnings from Continuing Operations | -138.00K | -144.10K | 276.70K | 941.40K | -137.50K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -138.00K | -144.10K | 276.70K | 941.40K | -137.50K |
| EBIT | -182.90K | -174.30K | 343.50K | 1.19M | -137.50K |
| EBITDA | -179.20K | -170.50K | 347.30K | 1.19M | -133.70K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 206.52M | 206.52M | 206.52M | 206.53M | 205.46M |
| Average Diluted Shares Outstanding | 206.52M | 206.52M | 206.52M | 206.53M | 205.46M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |